FOLH1 and adenocarcinoma: Unlike other cell-surface prostate adenocarcinoma targets, such as prostate stem cell antigen (PSCA), prostate-specific membrane antigen (PSMA), and six-transmembrane epithelial antigen of the prostate (STEAP-1)7,39, LeY is expressed on a broad spectrum of tumors.